Oct 2026· The Laryngoscope· 0 citations· 23 references
Medicine
TL;DR
While HFNC offers an ideal tubeless field for short interventions, its use is limited by time-dependent hypercapnia and progressive respiratory acidosis; for longer endolaryngeal procedures, HFJV is preferred to maintain ventilatory and metabolic homeostasis.
Abstract
Objectives
Shared airway management in endolaryngeal surgery conflicts surgical access with adequate ventilation. This study compared the effects of High-Frequency Jet Ventilation (HFJV) and Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) via High-Flow Nasal Cannula (HFNC) on perioperative oxygenation, arterial CO2 kinetics, and metabolic stability.
Methods
In this prospective randomized controlled study, 36 patients (ASA I-II) undergoing elective endolaryngeal procedures were randomized into HFJV (n = 18) or HFNC (n = 18) groups. Both cohorts received standardized TIVA and neuromuscular blockade. Primary outcomes were longitudinal PaCO2 changes at five intervals: baseline (T0), 10 (T1), 20 (T2), 30 (T3) minutes post-induction, and at surgical conclusion (T4). Secondary outcomes included PaO2, pH, and lactate.
Results
PaCO2 levels were comparable at T0 and T1. At 20 min (T2), PaCO2 was significantly higher in the HFNC group (55.5 vs. 44.5 mmHg; p = 0.002). At surgical conclusion (T4), median PaCO2 reached 66.5 mmHg in the HFNC group versus 44.5 mmHg in the HFJV group (p < 0.001). Consequently, the HFNC group exhibited significantly lower pH (7.21 vs. 7.31; p < 0.001) and elevated lactate (3.4 vs. 2.5 mmol/L; p < 0.001) at T4. PaO2 levels at T3 and T4 were significantly superior in the HFJV group (p < 0.001).
Conclusion
While HFNC offers an ideal tubeless field for short interventions, its use is limited by time-dependent hypercapnia and progressive respiratory acidosis. We propose a clinical "20-min threshold" for HFNC; for longer endolaryngeal procedures, HFJV is preferred to maintain ventilatory and metabolic homeostasis.
TRIAL REGISTRATION
This clinical trial was registered at ClinicalTrials.gov (registration number NCT05746949).
LEVEL OF EVIDENCE: 2
The benefit of HFNC was consistent in direction across sedation depth, procedure type, baseline risk and comparator device, although heterogeneity in magnitude was substantial and was driven chiefly by trials with matched nominal FiO₂ or very high control-arm risk.
Muhamad Luthfi Asyhar, Chaerunnisa Auliya Putu Sugiyarti, Jeremia J. P. Munthe et al.· The Indonesian Journal of Ge...· 0 citations
BACKGROUND
Postoperative neurosurgical patients who successfully pass a spontaneous breathing trial (SBT) may still require delayed extubation due to impaired airway protection. Continued mechanical ventilation may contribute to diaphragm underuse. High-flow tracheal oxygen (HFTO) offers an alternative-discontinuing po...
Yi-Min Zhou, Yan-Zhao Ma, Ye Tian et al.· Neurocritical Care· 0 citations
BACKGROUND AND OBJECTIVE
Non-invasive ventilation (NIV) is the first-line treatment for acute pulmonary edema (APE). However, with the development of high-flow nasal cannula oxygen therapy (HFNC), recent small-sample prospective studies have suggested comparable efficacy between HFNC and NIV in treating acute cardiogen...
Qiao-Yun Huang, Jian-Yi Niu, S. Zha et al.· Respirology (Carlton South....· 0 citations
BACKGROUND
Cardiac surgery with cardiopulmonary bypass structurally alters respiratory mechanics and carries a substantial risk of postoperative morbidity. Historically, patients have routinely received conventional oxygen therapy (COT) following extubation. High- flow nasal cannula (HCNC) therapy has emerged as an inn...
Muhammad Mustafa Khan, Zaryab Bacha, F. Khan et al.· Journal of Cardiothoracic an...· 0 citations
OBJECTIVES
To compare the clinical efficacy of 5 noninvasive ventilatory strategies-delivered via a conventional oronasal mask, a conventional full-face mask, the Wolf Mask full-face interface, the ELMO helmet (continuous positive airway pressure), and high-flow nasal cannula-against conventional physiotherapy without...
B. Okubo, J. G. Lobo, H. G. Lobo et al.· Journal of Cardiothoracic an...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.